HealthCor Management’s Celgene Corp CELG Stock Holding History

HealthCor Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,947,640	Closed	-$125M	–	67
2018 Q4	$125M	Buy	1,947,640 +1,011,472	+108%	+$74.7M	3.9%	9
2018 Q3	$83.8M	Sell	936,168 -16,502	-2%	-$1.46M	2.78%	15
2018 Q2	$75.7M	Buy	952,670 +271,640	+40%	+$22.6M	2.4%	16
2018 Q1	$60.8M	Sell	681,030 -1,043,970	-61%	-$100M	2.07%	16
2017 Q4	$180M	Buy	1,725,000 +1,181,820	+218%	+$133M	5.86%	4
2017 Q3	$79.2M	Sell	543,180 -1,381,820	-72%	-$188M	2.65%	13
2017 Q2	$250M	Buy	1,925,000 +525,000	+38%	+$64.3M	9.02%	2
2017 Q1	$174M	Sell	1,400,000 -100,000	-7%	-$12M	7.99%	3
2016 Q4	$174M	Buy	1,500,000 +1,356,150	+943%	+$151M	9.81%	1
2016 Q3	$15M	Buy	+143,850	New	+$15.6M	0.92%	26
2016 Q2	–	Sell	-155,660	Closed	-$15.6M	–	54
2016 Q1	$15.6M	Buy	+155,660	New	+$16M	0.88%	31
2015 Q1	–	Sell	-181,600	Closed	-$20.3M	–	89
2014 Q4	$20.3M	Buy	+181,600	New	+$19.2M	1.13%	31

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HealthCor Management's CELG Position: Q1 2019 in Review

HealthCor Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 1,947,640 shares — an estimated $125M sold.

HealthCor Management first reported a position in CELG in Q4 2014 and held it in 12 quarters. The position peaked at $250M in Q2 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

HealthCor Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
HealthCor Management sold 1,947,640 Celgene Corp shares in Q1 2019, an estimated $125M.
HealthCor Management first reported a position in Celgene Corp in Q4 2014 and held it in 12 quarters.
HealthCor Management's Celgene Corp position peaked at $250M in Q2 2017.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on HealthCor Management's 13F filing for Q1 2019, filed 15 May 2019.